Scott Weir, PharmD, PhD
Cures Within Reach, a leading global nonprofit organization focused on drug repurposing research, announced that Scott Weir, PharmD, PhD, of The University of Kansas Cancer Center, is the recipient of the 2018 Janet Davison Rowley Patient Impact Research Award. Dr. Weir serves as Director of the Institute for Advancing Medical Innovation and as Associate Director for Translational Research at The University of Kansas Cancer Center.
Cures Within Reach selected Dr. Weir for his work in advancing 12 repurposed drugs for patients with cancer into clinical trials, as the co-inventor of a repurposed antifungal therapy to treat bladder cancer, and as an acknowledged thought leader in the repurposing field. Repurposing research clinically tests approved drugs, devices, and nutraceuticals to find new treatments for various diseases.
The Janet Davison Rowley Patient Impact Research Award recognizes researchers and clinicians who have successfully repurposed a drug, device, or nutraceutical for human clinical use, published their repurposed treatment results in the clinical or scientific literature, and provided patients with enhanced quality of life through the repurposed treatment developed. ■
